Matches in SemOpenAlex for { <https://semopenalex.org/work/W1617899534> ?p ?o ?g. }
Showing items 1 to 63 of
63
with 100 items per page.
- W1617899534 abstract "Diabetic retinopathy (DR) is a neovascular, inflammatory and neurodegenerative disease. The neovascular component is treatable but no therapeutic agents are available for the other two components. Early changes in the diabetic retina include neuronal death of amacrine and retinal ganglion cells (RGC)(Barber et al., J Clin Invest,1998), and elevated levels of inflammatory mediators (Yoshimura et al., Plos One,2009). Nerve Growth factor (NGF) receptors, namely TrkA and p75NTR, are expressed in RGC. The TrkA receptor activates prosurvival, while p75NTR activates inflammatory and apoptotic pathways (Mysona et al., Expert Rev Ophthalmol,2014). Dehydroepiandrosterone (DHEA) binds to both receptors, mimicking NGF. It affords anti-apoptotic, neuroprotective and anti-inflammatory effects in the retina (Kokona et al., Neuro-pharmacol, 2012, Straub et al., J Clin Endocrinol, 1998). The therapeutic use of DHEA is restricted due to its metabolic products. The main objective of this study was to investigate and compare the neuroprotective and anti-inflammatory effects of DHEA and its spiro-epoxy derivatives BNN27 and BNN20(Calogeropoulou et al., J Med Chem,2009) (not metabolized to estrogens and androgens), in the rat streptozotocin model of DR. BNN27, via TrkA activation, protected in a dose-dependent manner (2, 10, 50mg/kg, ip) bNOS (brain nitric oxide synthetase) and TH (tyrosine hydroxylase) expressing amacrine cells and ganglion axons (NFL immunoreactivity) similar to DHEA’s actions, while BNN20 was less effective. BNN27 activated the TrkA prosurvival signaling pathway ERK1/2 kinase. It reduced the activation of SAPK/JNK kinase and the expression of p75NTR. BNN27 also increased the expression of anti-inflammatory cytokines (IL10). These results suggest that NGF TrkA receptor is involved in the neuroprotective and anti-inflammatory effects of BNN27 and is a valuable target via which BNN27 could afford efficacious therapeutics for the treatment of DR." @default.
- W1617899534 created "2016-06-24" @default.
- W1617899534 creator A5011735999 @default.
- W1617899534 creator A5033560526 @default.
- W1617899534 creator A5056129899 @default.
- W1617899534 creator A5057814414 @default.
- W1617899534 creator A5061638195 @default.
- W1617899534 creator A5073294960 @default.
- W1617899534 date "2015-06-12" @default.
- W1617899534 modified "2023-09-26" @default.
- W1617899534 title "Effects of novel synthetic microneurotrophins in diabetic retinopathy" @default.
- W1617899534 doi "https://doi.org/10.1186/2193-1801-4-s1-l25" @default.
- W1617899534 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4797964" @default.
- W1617899534 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27386188" @default.
- W1617899534 hasPublicationYear "2015" @default.
- W1617899534 type Work @default.
- W1617899534 sameAs 1617899534 @default.
- W1617899534 citedByCount "3" @default.
- W1617899534 countsByYear W16178995342018 @default.
- W1617899534 countsByYear W16178995342021 @default.
- W1617899534 countsByYear W16178995342023 @default.
- W1617899534 crossrefType "journal-article" @default.
- W1617899534 hasAuthorship W1617899534A5011735999 @default.
- W1617899534 hasAuthorship W1617899534A5033560526 @default.
- W1617899534 hasAuthorship W1617899534A5056129899 @default.
- W1617899534 hasAuthorship W1617899534A5057814414 @default.
- W1617899534 hasAuthorship W1617899534A5061638195 @default.
- W1617899534 hasAuthorship W1617899534A5073294960 @default.
- W1617899534 hasBestOaLocation W16178995341 @default.
- W1617899534 hasConcept C134018914 @default.
- W1617899534 hasConcept C2522767166 @default.
- W1617899534 hasConcept C2779829184 @default.
- W1617899534 hasConcept C41008148 @default.
- W1617899534 hasConcept C555293320 @default.
- W1617899534 hasConcept C71924100 @default.
- W1617899534 hasConceptScore W1617899534C134018914 @default.
- W1617899534 hasConceptScore W1617899534C2522767166 @default.
- W1617899534 hasConceptScore W1617899534C2779829184 @default.
- W1617899534 hasConceptScore W1617899534C41008148 @default.
- W1617899534 hasConceptScore W1617899534C555293320 @default.
- W1617899534 hasConceptScore W1617899534C71924100 @default.
- W1617899534 hasIssue "S1" @default.
- W1617899534 hasLocation W16178995341 @default.
- W1617899534 hasLocation W16178995342 @default.
- W1617899534 hasLocation W16178995343 @default.
- W1617899534 hasLocation W16178995344 @default.
- W1617899534 hasOpenAccess W1617899534 @default.
- W1617899534 hasPrimaryLocation W16178995341 @default.
- W1617899534 hasRelatedWork W1996408511 @default.
- W1617899534 hasRelatedWork W2183441170 @default.
- W1617899534 hasRelatedWork W2336590402 @default.
- W1617899534 hasRelatedWork W2367206690 @default.
- W1617899534 hasRelatedWork W2400214213 @default.
- W1617899534 hasRelatedWork W2401570230 @default.
- W1617899534 hasRelatedWork W2748952813 @default.
- W1617899534 hasRelatedWork W2899084033 @default.
- W1617899534 hasRelatedWork W2935854619 @default.
- W1617899534 hasRelatedWork W4247880953 @default.
- W1617899534 hasVolume "4" @default.
- W1617899534 isParatext "false" @default.
- W1617899534 isRetracted "false" @default.
- W1617899534 magId "1617899534" @default.
- W1617899534 workType "article" @default.